NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

69.30

-0.33

(-0.47%)

As of 11:57 AM EDT. Market Open.

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks yesterday

CVS
-0.47%
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.

Zacks 3 days ago

CVS
-0.47%
Alvotech deal could heighten biosimilar pressure on Humira

The agreement may help Alvotech capitalize on a recent policy shift by CVS that has driven major market share declines for AbbVie’s blockbuster drug.

BioPharma Dive 4 days ago

CVS
-0.47%
CVS Health (CVS) Rises As Market Takes a Dip: Key Facts

CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.

Zacks 4 days ago

CVS
-0.47%
Elevance Health Offers More Relief on Medical Costs for Worried Investors

Elevance Health offered skittish investors another signal that health insurers aren’t getting hit with higher-than-expected costs, reporting results that beat Wall Street expectations. Elevance stock rose over 5% early Thursday, on track for its highest close since December 2022. The earnings may help sustain a rally that began Tuesday, when UnitedHealth released results that also came in above analysts’ projections and said healthcare expenses were running at expected rates.

The Wall Street Journal 5 days ago

CVS
-0.47%
UNH
-0.55%
ELV
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks 5 days ago

CVS
-0.47%
CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

The strength of a diversified enterprise, along with robust operational execution, is expected to be reflected in CVS Health's (CVS) first-quarter 2024 results.

Zacks 5 days ago

CVS
-0.47%
CVS Health Corp's Dividend Analysis

CVS Health Corp (NYSE:CVS) recently announced a dividend of $0.67 per share, payable on 2024-05-01, with the ex-dividend date set for 2024-04-19. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into CVS Health Corp's dividend performance and assess its sustainability.

GuruFocus.com 5 days ago

CVS
-0.47%
3 Defensive Stocks to Buy for Increased Volatility in April

As the earnings season gets underway on Wall Street, the euphoria of rapid gains is starting to wane. Economic uncertainties, geopolitical tensions and the ever-present threat of inflation have left investors feeling like they’re navigating a constant financial storm. In such turbulent times, the appeal of defensive stocks becomes increasingly clear. These resilient companies, often found in sectors like consumer staples, healthcare and utilities, offer a safe haven during increased volatility.

InvestorPlace 6 days ago

CVS
-0.47%
GIS

^GSPC
Free Cash Flow ETFs See Continued Investor Interest

VictoryShares’ lineup of free cash flow ETFs has seen continued interest among investors. The VictoryShares Free Cash Flow ETF (VFLO) and the VictoryShares Small Cap Free Cash Flow ETF (SFLO) attracted strong interest and healthy flows in February 2024. VFLO saw over $31 million in net flows between February 1 and February 29, while the younger SFLO saw [...]

ETF Trends 6 days ago

CVS
-0.47%
U.S. Probes High Generic Drug Prices

The U.S. government is investigating whether the consolidation of health insurers, pharmacy benefit managers and pharmacies is fueling high drug costs. The Department of Health and Human Services’ Office of Inspector General said it is examining whether health insurers' shared ownership of pharmacy-benefit managers and pharmacies has played a role in high drug prices. “We will determine the impact of related entity transactions within select vertically integrated entities on the prices for covered Part D drugs,” the OIG said in an undated post on its website.

The Wall Street Journal 6 days ago

CVS
-0.47%
CI

UNH
-0.55%
Heard on the Street: Beaten-Down Health Insurers Take a Breather—for Now

Health insurance stocks have been so battered this year that it doesn’t take much good news to move them higher. On Tuesday, UnitedHealth said its first-quarter adjusted earnings topped Wall Street’s estimates, despite a cyberattack on one of its units that weighed on the healthcare and insurance company’s results. Crucially for investors, UnitedHealth’s results implied that if one strips out some one-time costs associated with the cyberattack earlier this year, its core medical-loss ratio—a key measure of medical expenses—was about 83.9%, roughly in line with Wall Street estimates.

The Wall Street Journal 6 days ago

HUM

CVS
-0.47%
UNH
-0.55%
EXPLAINER-Why are US pharmacy benefit managers under fire?

Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month's U.S. government budget deal. Many lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play a critical role in high prescription drug costs in the United States. The following is what you need to know about PBMs.

Reuters 7 days ago

UNH
-0.55%
CVS
-0.47%
CI
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina

Friday, the Agency for Health Care Administration announced contracts to five health plans due for the re-procurement of the Statewide Medicaid Managed Care (SMMC) program. Florida has finally announced its long-awaited Medicaid contract awards, keeping Centene Inc (NYSE:CNC), Elevance Health Inc (NYSE:ELV), and Humana Inc (NYSE:HUM) as the only providers in each state region. Stephens noted that Centene and Elevance Health re-procured specialty contracts (MMASC) while Centene also retained its

Benzinga 7 days ago

CNC

HUM

ELV
UnitedHealth’s Earnings Could Illuminate True Fallout From Cyberattack on Change Unit

Investors might get a better sense of the fallout for UnitedHealth Group when it reports first-quarter earnings results Tuesday.

The Wall Street Journal 9 days ago

HUM

UNH
-0.55%
CVS
-0.47%
CVS Health (CVS) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, CVS Health (CVS) stood at $68.64, denoting a -1.58% change from the preceding trading day.

Zacks 10 days ago

CVS
-0.47%
Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now

In a setting historically dominated by male leadership, women at the helm of major corporations is still considered something of a novelty. You don’t see many articles about a company’s first male CEO, but there’s always a buzz when the first woman gets hired to the same position. As of January 2023 only 10% of the Fortune 500 companies were run by a woman. That’s surprising considering a study conducted by S&P Global found that in the two years following their appointment, “female CEOs saw a 20

InvestorPlace 10 days ago

CVS
-0.47%
GM
Why big Medicare Advantage insurers may root for Biden to lose in 2024

Insurance giants have a bigger stake in this year’s presidential election after recent moves by the Biden administration cut into the profitability of Medicare Advantage plans.

Yahoo Finance 12 days ago

CNC

UNH
-0.55%
HUM
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services. It’s one of the essentials of life, which makes the industry such a politically sensitive matter. Besides the critical need, another element that helps bolster the case for healthcare stocks is the underlying diversity. Yes, the sector centers on the pharmaceutical innovation space. However,

InvestorPlace 12 days ago

TMO

UNH
-0.55%
JNJ
+0.41%
CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note

CVS Health (CVS) closed at $73.36 in the latest trading session, marking a -1.45% move from the prior day.

Zacks 13 days ago

CVS
-0.47%

Performance Overview

Return	CVS	S&P 500
YTD	-10.58%	+6.11%
1-Year	-1.43%	+22.44%
3-Year	-1.00%	+22.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CVS Health Corporation (CVS)

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

Alvotech deal could heighten biosimilar pressure on Humira

CVS Health (CVS) Rises As Market Takes a Dip: Key Facts

Elevance Health Offers More Relief on Medical Costs for Worried Investors

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

CVS Health Corp's Dividend Analysis

3 Defensive Stocks to Buy for Increased Volatility in April

Free Cash Flow ETFs See Continued Investor Interest

U.S. Probes High Generic Drug Prices

Heard on the Street: Beaten-Down Health Insurers Take a Breather—for Now

EXPLAINER-Why are US pharmacy benefit managers under fire?

See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina

UnitedHealth’s Earnings Could Illuminate True Fallout From Cyberattack on Change Unit

CVS Health (CVS) Declines More Than Market: Some Information for Investors

Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now

Why big Medicare Advantage insurers may root for Biden to lose in 2024

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note

Performance Overview